Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus

Abstract

The main aim of this cross-sectional study was to investigate the association between pulse pressure amplification (PPA) and cardiac autonomic activity (baroreflex sensitivity (BRS) and heart rate variability (HRV)) in patients with type 2 diabetes mellitus (T2DM). In addition, we examined the association between cardiac autonomic activity and central hemodynamic parameters that may affect PPA such as augmentation index (AIx), aortic stiffness (pulse wave velocity (PWV)), and common carotid artery stiffness distensibility coefficient (DC). A total of 142 patients with T2DM were included in the study. In multivariate linear regression analysis—after controlling for age, diabetes duration, height, waist circumference, aortic PWV, use of β-blockers, and BRS—PPA was associated significantly and independently with male gender (standardized regression coefficient (β) = 0.156, p = 0.007), aortic systolic blood pressure (β = −0.221, p < 0.001), heart rate (β = 0.521, p < 0.001), AΙx (β = −0.443, p < 0.001), and parameters of HRV, such as total power of HRV (β = −0.157, p = 0.005). No significant associations were found between BRS or parameters of HRV with aortic PWV, AIx, or DC. In patients with T2DM, cardiac autonomic dysfunction was associated with enhanced PPA. This association was independent from the well-described effect of resting heart rate, as well as from traditional cardiovascular risk factors or diabetes-related factors. Moreover, it was not mediated by effects of the autonomic dysfunction on arterial stiffness or on pressure wave reflections. These findings suggest that cardiac autonomic dysfunction affects PPA by mechanisms other than resting tachycardia and arterial properties.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.

    Article  CAS  PubMed  Google Scholar 

  2. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865–71.

    Article  PubMed  Google Scholar 

  3. McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014;35:1719–25.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27.

    Article  PubMed  Google Scholar 

  5. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol. 2010;55:1032–7.

    Article  PubMed  Google Scholar 

  6. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: experts’ opinion and review of the data. Hypertension. 2009;54:375–83.

    Article  CAS  PubMed  Google Scholar 

  7. Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens. 2007;20:127–33.

    Article  PubMed  Google Scholar 

  8. Yannoutsos A, Ahouah M, Tubiana CD, Topouchian J, Touboul C, Safar ME, et al. Hemodynamic parameters in hypertensive diabetic patients. J Hypertens. 2016;34:1123–31.

    Article  CAS  PubMed  Google Scholar 

  9. Agnoletti D, Lieber A, Zhang Y, Protogerou AD, Borghi C, Blacher J, et al. Central hemodynamic modifications in diabetes mellitus. Atherosclerosis. 2013;230:315–21.

    Article  CAS  PubMed  Google Scholar 

  10. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387–97.

    Article  PubMed  Google Scholar 

  11. Karayannis G, Giamouzis G, Cokkinos DV, Skoularigis J, Triposkiadis F. Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther. 2012;10:747–65.

    Article  CAS  PubMed  Google Scholar 

  12. Vergnaud AC, Protogerou AD, Li Y, Czernichow S, Vesin C, Blacher J, et al. Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: the role of heart rate. Atherosclerosis. 2008;199:222–9.

    Article  CAS  PubMed  Google Scholar 

  13. American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:S13–27.

    Article  Google Scholar 

  14. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.

    Article  PubMed  Google Scholar 

  15. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95:1827–36.

    Article  CAS  PubMed  Google Scholar 

  16. Reference Values for Arterial Stiffness C. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010;31:2338–50.

    Article  Google Scholar 

  17. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, et al. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens. 2002;15:445–52.

    Article  PubMed  Google Scholar 

  18. Grigoropoulou P, Eleftheriadou I, Zoupas C, Makrilakis K, Papassotiriou I, Margeli A, et al. Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia. Diab Vasc Dis Res. 2014;11:26–33.

    Article  PubMed  Google Scholar 

  19. Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, Papazafiropoulou A, Katsilambros N. Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity. Obesity. 2007;15:1685–93.

    Article  PubMed  Google Scholar 

  20. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51:1476–82.

    Article  CAS  PubMed  Google Scholar 

  21. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003;41:183–7.

    Article  CAS  PubMed  Google Scholar 

  22. Liatis S, Alexiadou K, Tsiakou A, Makrilakis K, Katsilambros N, Tentolouris N. Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res. 2011;2011:957901.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chorepsima S, Eleftheriadou I, Tentolouris A, Moyssakis I, Protogerou A, Kokkinos A, et al. Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus. BMC Endocr Disord. 2017;17:27.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Jin HY, Baek HS, Park TS. Morphologic changes in autonomic nerves in diabetic autonomic neuropathy. Diabetes Metab J. 2015;39:461–7.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Jaiswal M, Urbina EM, Wadwa RP, Talton JW, D’Agostino RB Jr., Hamman RF, et al. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes care. 2013;36:2351–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

No support was received for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nikolaos Tentolouris.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eleftheriadou, I., Drosos, G.C., Tentolouris, A. et al. Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus. J Hum Hypertens 32, 531–539 (2018). https://doi.org/10.1038/s41371-018-0070-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-018-0070-1

Search

Quick links